Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19

Creative Commons License

Erdogan M., Kalem A. K., Ozturk S., Erdol M. A., Kayaaslan B., Ozbebek Y. E., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.25, no.8, pp.555-565, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 8
  • Publication Date: 2021
  • Doi Number: 10.5152/anatoljcardiol.2021.24946
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.555-565
  • Keywords: coronavirus disease 2019, interleukin-6, transthoracic echocardiography, right ventricle, EUROPEAN ASSOCIATION, MYOCARDIAL INJURY, AMERICAN SOCIETY, ECHOCARDIOGRAPHY, ADULTS, WUHAN, IL-6
  • Yozgat Bozok University Affiliated: No


Objective: Cytokine storm with elevated levels of multiple proinflammatory cytokines and inflammatory system activation underlie the pathogenesis of coronavirus disease 2019 (COVID-19). In this study, we aimed to investigate whether increased interleukin (IL)-6 levels can predict right ventricular (RV) systolic impairment in patients hospitalized with COVID-19.